Literature DB >> 23089582

Characterization of reducible peptide oligomers as carriers for gene delivery.

Anton Kiselev1, Anna Egorova, Antti Laukkanen, Vladislav Baranov, Arto Urtti.   

Abstract

The stability of DNA-polyplexes and intracellular DNA release are important features of gene delivery systems. To study these features, we have evaluated reducible cysteine-flanked linear lysine and arginine-rich peptides, modified with histidine residues. The reducible disulfide bonds in cysteine flanked peptides and histidine residues should augment DNA release from the peptide-DNA complexes upon disintegration of the reducible bonds. Template polymerization and oxidative polycondensation were applied to obtain peptide oligomers used for DNA-polyplex preparation. The peptides and DNA-peptide complexes were investigated with physical, chemical and transfection measurements. Physicochemical and transfection properties of DNA-polyplexes depended on the amino acid sequence of the peptidic polymers and type of the polymerization. MALDI-TOF analysis of oxidatively polycondensed products revealed several forms of peptide oligomers corresponding to 5-8 amino acid monomers. DNA-peptide particles based on template-polymerized complexes were more resistant to relaxation by negatively charged heparan sulfate than polyplexes formed with oxidatively condensed peptides. Complexes of DNA with the polycations prepared by oxidative polycondensation exhibited a 100-1000-fold higher level of gene expression compared to DNA/template-polymerized peptide complexes. The most efficient transgene expression was shown with arginine-rich polyplexes. Transfection efficacy of the arginine-rich polyplexes was even 10-fold better than that of DNA/PEI complexes. On average, polyplexes based on cysteine-flanked peptide oligomers showed lower cytotoxicity than non-reducible high molecular weight polylysine/DNA particles. We conclude that reducible peptide oligomers provide efficient DNA transfection and have the potential as vehicles for gene delivery.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089582     DOI: 10.1016/j.ijpharm.2012.10.020

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

1.  Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes.

Authors:  Anna A Egorova; Sofia V Shtykalova; Marianna A Maretina; Dmitry I Sokolov; Sergei A Selkov; Vladislav S Baranov; Anton V Kiselev
Journal:  Pharmaceutics       Date:  2019-06-06       Impact factor: 6.321

2.  Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma.

Authors:  Anna Egorova; Sofia Shtykalova; Alexander Selutin; Natalia Shved; Marianna Maretina; Sergei Selkov; Vladislav Baranov; Anton Kiselev
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

3.  Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells.

Authors:  Anna Egorova; Sofia Shtykalova; Marianna Maretina; Alexander Selutin; Natalia Shved; Dmitriy Deviatkin; Sergey Selkov; Vladislav Baranov; Anton Kiselev
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

4.  Reducible chimeric polypeptide consisting of octa-D-arginine and tetra-L-histidine peptides as an efficient gene delivery vector.

Authors:  Xiaoyu Wang; Zongguang Tai; Jing Tian; Wei Zhang; Chong Yao; Lijuan Zhang; Yuan Gao; Quangang Zhu; Jing Gao; Shen Gao
Journal:  Int J Nanomedicine       Date:  2015-07-22

5.  Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma.

Authors:  Sofia Shtykalova; Anna Egorova; Marianna Maretina; Vladislav Baranov; Anton Kiselev
Journal:  Bioengineering (Basel)       Date:  2022-03-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.